Martiniello-Wilks R - Search Results

1

Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer.

Martiniello-Wilks R, Wang XY, Voeks DJ, Dane A, Shaw JM, Mortensen E, Both GW, Russell PJ. Martiniello-Wilks R, et al. J Gene Med. 2004 Dec;6(12):1343-57. doi: 10.1002/jgm.629. J Gene Med. 2004. PMID: 15493036

2

Transcription-targeted gene therapy for androgen-independent prostate cancer.

Martiniello-Wilks R, Tsatralis T, Russell P, Brookes DE, Zandvliet D, Lockett LJ, Both GW, Molloy PL, Russell PJ. Martiniello-Wilks R, et al. Cancer Gene Ther. 2002 May;9(5):443-52. doi: 10.1038/sj.cgt.7700451. Cancer Gene Ther. 2002. PMID: 11961667

3

Application of the transgenic adenocarcinoma mouse prostate (TRAMP) model for pre-clinical therapeutic studies.

Martiniello-Wilks R, Dane A, Mortensen E, Jeyakumar G, Wang XY, Russell PJ. Martiniello-Wilks R, et al. Anticancer Res. 2003 May-Jun;23(3B):2633-42. Anticancer Res. 2003. PMID: 12894551

4

Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease.

Martiniello-Wilks R, Dane A, Voeks DJ, Jeyakumar G, Mortensen E, Shaw JM, Wang XY, Both GW, Russell PJ. Martiniello-Wilks R, et al. J Gene Med. 2004 Jan;6(1):43-54. doi: 10.1002/jgm.474. J Gene Med. 2004. PMID: 14716676

5

Combination of cytosine deaminase with uracil phosphoribosyl transferase leads to local and distant bystander effects against RM1 prostate cancer in mice.

Khatri A, Zhang B, Doherty E, Chapman J, Ow K, Pwint H, Martiniello-Wilks R, Russell PJ. Khatri A, et al. J Gene Med. 2006 Sep;8(9):1086-96. doi: 10.1002/jgm.944. J Gene Med. 2006. PMID: 16832832

6

In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors.

Martiniello-Wilks R, Garcia-Aragon J, Daja MM, Russell P, Both GW, Molloy PL, Lockett LJ, Russell PJ. Martiniello-Wilks R, et al. Hum Gene Ther. 1998 Jul 20;9(11):1617-26. doi: 10.1089/hum.1998.9.11-1617. Hum Gene Ther. 1998. PMID: 9694160

7

Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models.

Voeks D, Martiniello-Wilks R, Madden V, Smith K, Bennetts E, Both GW, Russell PJ. Voeks D, et al. Gene Ther. 2002 Jun;9(12):759-68. doi: 10.1038/sj.gt.3301698. Gene Ther. 2002. PMID: 12040457

8

Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus.

Wang XY, Martiniello-Wilks R, Shaw JM, Ho T, Coulston N, Cooke-Yarborough C, Molloy PL, Cameron F, Moghaddam M, Lockett TJ, Webster LK, Smith IK, Both GW, Russell PJ. Wang XY, et al. Gene Ther. 2004 Nov;11(21):1559-67. doi: 10.1038/sj.gt.3302308. Gene Ther. 2004. PMID: 15343359

9

Derivation of MPR and TRAMP models of prostate cancer and prostate cancer metastasis for evaluation of therapeutic strategies.

Voeks DJ, Martiniello-Wilks R, Russell PJ. Voeks DJ, et al. Urol Oncol. 2002 May-Jun;7(3):111-8. doi: 10.1016/s1078-1439(01)00180-6. Urol Oncol. 2002. PMID: 12474544

10

Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy?

Tang C, Russell PJ, Martiniello-Wilks R, Rasko JE, Khatri A. Tang C, et al. Stem Cells. 2010 Sep;28(9):1686-702. doi: 10.1002/stem.473. Stem Cells. 2010. PMID: 20629172 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters